LIVN (LivaNova) Total Operating Expense: $775 Mil (TTM As of Mar. 2026)


LIVN LivaNova PLC LIVN
76 GF Score
Price $83.61
GF Value $62.55
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova Total Operating Expense?

LivaNova LIVN +1.35% 76 Total Operating Expense is $775 Mil as of Mar. 2026. GuruFocus rates LIVN with a GF Score™ of 76/100 and a GF Value™ of $62.55 (Significantly Overvalued). The stock has 7 warning signs investors should review.

LivaNova's Total Operating Expense for the three months ended in Mar. 2026 was $202 Mil. LivaNova's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $775 Mil.

LivaNova Total Operating Expense Related Terms

LivaNova Total Operating Expense Historical Data

* Premium members only.

The historical data trend for LivaNova's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Total Operating Expense Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 706.78 654.58 734.34 724.43 740.48

LivaNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.64 184.81 190.84 197.20 202.30
LIVN
76GF Score
LivaNova PLC LIVN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LivaNova Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $775 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $775 Mil mean?
LivaNova (LIVN) has a Total Operating Expense of $775 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on LivaNova and its competitors.
Is LivaNova's Total Operating Expense too high?
LivaNova's current Total Operating Expense is $775 Mil. Overall, LivaNova has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's Total Operating Expense compare to IRTC and HAE?
LivaNova's Total Operating Expense of $775 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on LivaNova and its competitors. LivaNova's current Total Operating Expense is $775 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (LIVN) is currently considered Significantly Overvalued. The stock's GF Value™ is $62.55, compared to a current price of $83.61 — trading 33.7% above its estimated fair value. The current Total Operating Expense is $775 Mil. LivaNova's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For LivaNova (LIVN), the current Total Operating Expense is $775 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LivaNova (LIVN) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of $83.61 is trading 33.7% above its estimated GF Value™ of $62.55. GuruFocus considers LivaNova to be Significantly Overvalued.

Key valuation signals for LIVN:

  • Total Operating Expense: $775 Mil
  • GF Value™: $62.55 vs. price of $83.61 (33.7% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the LIVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIA:Germany
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
76GF Score

Get the complete analysis for LIVN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$83.61
Price
$62.55
GF Value